Cetirizine 10mg + Cetirizine 10 mg + Cetirizine 10 mg
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Allergy
Conditions
Allergy
Trial Timeline
Dec 11, 2018 → Feb 3, 2019
NCT ID
NCT03772158About Cetirizine 10mg + Cetirizine 10 mg + Cetirizine 10 mg
Cetirizine 10mg + Cetirizine 10 mg + Cetirizine 10 mg is a phase 1 stage product being developed by Johnson & Johnson for Allergy. The current trial status is completed. This product is registered under clinical trial identifier NCT03772158. Target conditions include Allergy.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03772158 | Phase 1 | Completed |
Competing Products
20 competing products in Allergy